Linperlisib in combined with Chidamide
Sponsors
Peking Union Medical College Hospital
Conditions
Cutaneous T-cell LymphomaPeripheral T Cell Lymphoma
Phase 1
Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study
NCT06037239
Start: 2023-07-01End: 2025-07-31Target: 53Updated: 2023-09-14
Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study
NCT06083701
Start: 2023-09-25End: 2025-09-25Target: 32Updated: 2023-10-16